The role of immunoglobulin kappa elements in c-myc activation.

Abstract:

:Burkitt's lymphoma cells are characterized by chromosomal translocations involving the proto-oncogene c-myc on chromosome 8 and one of the immunoglobulin gene loci on chromosome 2, 14 or 22. The translocated c-myc allele is transcriptionally activated, shows a preferential usage of promoter P1 over P2 (promoter shift) and lacks the ability to retain the transcription complex at the P2 promoter. In order to define the elements of the immunoglobulin kappa gene involved in deregulation of c-myc in a t(2;8) translocation, we designed constructs consisting of c-myc and different parts of the immunoglobulin kappa gene locus. Chromatin analysis of these stably transfected constructs revealed DNase I hypersensitive sites within the c-myc 5' region characteristic for an actively transcribed c-myc gene and three sites within the immunoglobulin kappa locus corresponding to the matrix attachment region, the intron and 3' enhancers, respectively. These three regulatory elements were necessary and sufficient for maximal c-myc activation and formation of the promoter shift. Kinetic nuclear run on experiments were performed to study the distribution of transcription complexes on c-myc exon 1 on constructs with and without the immunoglobulin kappa regulatory elements. The absence of a pausing polymerase complex at the c-myc P2 promoter could be demonstrated for constructs consisting of c-myc and the two kappa enhancers. Therefore the two enhancers are sufficient to relief the elongational block at the P2 promoter, however, the matrix attachment region is additionally required for maximal c-myc activation observed in Burkitt's lymphoma cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Hörtnagel K,Mautner J,Strobl LJ,Wolf DA,Christoph B,Geltinger C,Polack A

subject

Has Abstract

pub_date

1995-04-06 00:00:00

pages

1393-401

issue

7

eissn

0950-9232

issn

1476-5594

journal_volume

10

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.

    abstract::Tumor suppressor Pdcd4 has recently been shown to inhibit invasion by activating activator protein-1 (AP-1); however, little is known of the functionally significant Pdcd4-target genes. The urokinase receptor (u-PAR) promotes invasion/metastasis, and is associated with poor cancer-patient survival. The present study w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210234

    authors: Leupold JH,Yang HS,Colburn NH,Asangani I,Post S,Allgayer H

    更新日期:2007-07-05 00:00:00

  • NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.

    abstract::In chronic myelogenous leukemia (CML), the oncogene bcr-abl encodes a dysregulated tyrosine kinase that inhibits apoptosis. We showed previously that human erythroleukemia K562 cells are resistant to antineoplastic drug (taxol)-induced apoptosis through the atypical protein kinase C iota isozyme (PKC iota), a kinase d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204607

    authors: Lu Y,Jamieson L,Brasier AR,Fields AP

    更新日期:2001-08-09 00:00:00

  • A role for Myc in facilitating transcription activation by E2F1.

    abstract::Previous work has demonstrated that E2F proteins regulate the expression of various genes encoding proteins essential for DNA replication and cell-cycle progression. E2F1 in particular is required for the initial entry to the cell cycle from a quiescent state and is required for the activation of other E2F genes. Othe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.55

    authors: Leung JY,Ehmann GL,Giangrande PH,Nevins JR

    更新日期:2008-07-10 00:00:00

  • A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation.

    abstract::NUP98 has been involved in multiple recurrent chromosome rearrangements in leukemia. We identified a novel fusion between NUP98 and IQ motif containing G (IQCG) gene from a de novo acute T-lymphoid/myeloid leukemia harboring t(3;11)(q29q13;p15)del(3)(q29). IQCG has two putative coiled-coil domains and one IQ domain. T...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210999

    authors: Pan Q,Zhu YJ,Gu BW,Cai X,Bai XT,Yun HY,Zhu J,Chen B,Weng L,Chen Z,Xue YQ,Chen SJ

    更新日期:2008-05-29 00:00:00

  • Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.

    abstract::We report chromosome 3p deletion mapping of 32 cervical carcinoma (CC) biopsies using 26 microsatellite markers located in frequently deleted 3p regions to detect loss of heterozygosity and homozygous loss. In addition, two STS markers (NLJ-003 and NL3-001) located in the 3p21.3 telomeric (3p21.3T) and 3p21.3 centrome...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206429

    authors: Senchenko V,Liu J,Braga E,Mazurenko N,Loginov W,Seryogin Y,Bazov I,Protopopov A,Kisseljov FL,Kashuba V,Lerman MI,Klein G,Zabarovsky ER

    更新日期:2003-05-15 00:00:00

  • HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

    abstract::Amplified segments of the long arm of chromosome 12 are frequently observed in human sarcomas. In most cases there are separate amplified regions around the MDM2 and CDK4 genes. Here we show recurrent amplification of a third region encompassing HMGIC, a human architectural transcription factor gene. Reduced amplifica...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201135

    authors: Berner JM,Meza-Zepeda LA,Kools PF,Forus A,Schoenmakers EF,Van de Ven WJ,Fodstad O,Myklebost O

    更新日期:1997-06-19 00:00:00

  • Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.

    abstract::A new class of nontransformed revertant cells has been isolated from the ras-transformed cell line DT using cis-4-hydroxy-L-proline (CHP) as a selective agent. The new revertants, CHP 9CJ and CHP CB4, each contain two copies of the v-Ki-ras gene, elevated levels of phosphorylated p21ras protein, and rescuable transfor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yanagihara K,Ciardiello F,Talbot N,McGeady ML,Cooper H,Benade L,Salomon DS,Bassin RH

    更新日期:1990-08-01 00:00:00

  • Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia.

    abstract::A vector, derived from the human K1 keratin gene, has been employed to target v-fos expression exclusively in the epidermis of transgenic mice. Adult transgenic mice expressors (3-4 months) displayed hyperplasia and hyperkeratosis, initially in wounded (tagged) ears, which later became bilateral. This phenotype appear...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Greenhalgh DA,Rothnagel JA,Wang XJ,Quintanilla MI,Orengo CC,Gagne TA,Bundman DS,Longley MA,Fisher C,Roop DR

    更新日期:1993-08-01 00:00:00

  • Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase.

    abstract::Paxillin is a focal-adhesion associated protein implicated in the regulation of integrin signaling and organization of the actin cytoskeleton. Paxillin associates with numerous signaling molecules including adaptor molecules (p130Cas, CRK), kinases (FAK, Pyk2, PAK and SRC), tyrosine phosphatases (PTP-PEST), ARF-GAP pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205013

    authors: Wade R,Bohl J,Vande Pol S

    更新日期:2002-01-03 00:00:00

  • Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers.

    abstract::We previously reported the presence of mitotic check-point impairment in about 40% of lung cancer cell lines. To gain an insight into the molecular basis of this impairment, we examined 49 lung cancer specimens for alterations in the hMAD1 mitotic checkpoint gene and identified a somatic, non-conservative missense mut...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203141

    authors: Nomoto S,Haruki N,Takahashi T,Masuda A,Koshikawa T,Takahashi T,Fujii Y,Osada H,Takahashi T

    更新日期:1999-11-25 00:00:00

  • Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).

    abstract::An elevated proteasome activity contributes to tumorigenesis, particularly by providing cancer cells with antiapoptotic protection and efficient clearance from irregular proteins. Still, the underlying mechanisms are poorly known. In this study, we report that in colon cancer patients, higher proteasome activity was d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.264

    authors: Arlt A,Bauer I,Schafmayer C,Tepel J,Müerköster SS,Brosch M,Röder C,Kalthoff H,Hampe J,Moyer MP,Fölsch UR,Schäfer H

    更新日期:2009-11-12 00:00:00

  • A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

    abstract::Receptor tyrosine kinases of the Eph family are upregulated in several different types of cancer. One family member in particular, the EphA2 receptor, has been linked to breast, prostate, lung and colon cancer, as well as melanoma. However, mechanisms by which EphA2 contributes to tumor progression are far from clear....

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208937

    authors: Fang WB,Brantley-Sieders DM,Parker MA,Reith AD,Chen J

    更新日期:2005-11-24 00:00:00

  • Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN.

    abstract::Myc family proteins play an important role in cellular processes such as proliferation, differentiation, apoptosis and transformation. A number of interaction partners of Myc have been identified, such as Max, p107, TBP, YY1, Miz-1, AP-2 and Nmi. Both Max and Nmi also bind to MycN. In contrast to the well defined bind...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203090

    authors: Bannasch D,Weis I,Schwab M

    更新日期:1999-11-18 00:00:00

  • Isolation of HELAD1, a novel human helicase gene up-regulated in colorectal carcinomas.

    abstract::To investigate the mechanisms of colorectal carcinogenesis, we searched for genes regulated by adenomatous polyposis coli gene product (APC) and identified a novel gene, termed HELAD1 (helicase, APC down-regulated 1). A recombinant polypeptide representing the ATPases associated with cellular activities (AAA) domain o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205751

    authors: Ishiguro H,Shimokawa T,Tsunoda T,Tanaka T,Fujii Y,Nakamura Y,Furukawa Y

    更新日期:2002-09-12 00:00:00

  • Mechanisms of the androgen receptor splicing in prostate cancer cells.

    abstract::Prostate tumors develop resistance to androgen deprivation therapy (ADT) by multiple mechanisms, one of which is to express constitutively active androgen receptor (AR) splice variants lacking the ligand-binding domain. AR splice variant 7 (AR-V7, also termed AR3) is the most abundantly expressed variant that drives p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.284

    authors: Liu LL,Xie N,Sun S,Plymate S,Mostaghel E,Dong X

    更新日期:2014-06-12 00:00:00

  • Cancer whole-genome sequencing: present and future.

    abstract::Recent explosive advances in next-generation sequencing technology and computational approaches to massive data enable us to analyze a number of cancer genome profiles by whole-genome sequencing (WGS). To explore cancer genomic alterations and their diversity comprehensively, global and local cancer genome-sequencing ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.90

    authors: Nakagawa H,Wardell CP,Furuta M,Taniguchi H,Fujimoto A

    更新日期:2015-12-03 00:00:00

  • Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.

    abstract::WEE1 kinase has been described as a major gate keeper at the G2 cell cycle checkpoint and to be involved in tumour progression in different malignant tumours. Here we analysed the expression levels of WEE1 in a series of melanoma patient samples and melanoma cell lines using immunoblotting, quantitative real-time PCR ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.324

    authors: Bhattacharya A,Schmitz U,Wolkenhauer O,Schönherr M,Raatz Y,Kunz M

    更新日期:2013-06-27 00:00:00

  • Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells.

    abstract::Using Southern blot analysis of DNA from mouse-hamster somatic cell hybrids, we have mapped Lmyc and Bmyc, two members of the myc family of genes, to mouse chromosomes 4 and 2, respectively. Furthermore, we have compared the regulation of Lmyc and Bmyc expression under different growth conditions and during in vitro d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ingvarsson S,Sundaresan S,Jin P,Francke U,Asker C,Sümegi J,Klein G,Sejersen T

    更新日期:1988-12-01 00:00:00

  • R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.

    abstract::Within the superfamily of ras-related GTP-binding proteins, only ras itself has been shown to act as an oncogene. Seven other proteins, however, have greater than 50% amino acid identity to ras and one of them, rap1A, has been shown to interact with the ras GTPase activating protein, ras-GAP, and to inhibit ras functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rey I,Taylor-Harris P,van Erp H,Hall A

    更新日期:1994-03-01 00:00:00

  • SUMOylation inhibits FOXM1 activity and delays mitotic transition.

    abstract::The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.546

    authors: Myatt SS,Kongsema M,Man CW,Kelly DJ,Gomes AR,Khongkow P,Karunarathna U,Zona S,Langer JK,Dunsby CW,Coombes RC,French PM,Brosens JJ,Lam EW

    更新日期:2014-08-21 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap.

    abstract::A seven-transmembrane protein, frizzled, has been implicated in a planar cell polarity (PCP) pathway as well as the canonical Wnt signaling pathway. Although both pathways require a cytoplasmic protein, dishevelled, the molecular mechanism by which frizzled regulates intracellular signaling remains to be elucidated. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207817

    authors: Yao R,Natsume Y,Noda T

    更新日期:2004-08-12 00:00:00

  • Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

    abstract::A hallmark of cancer is the deregulation of cell-cycle machinery, ultimately facilitating aberrant proliferation that fuels tumorigenesis and disease progression. Particularly, in breast cancers, cyclin D1 has a crucial role in the development of disease. Recently, a highly specific inhibitor of CDK4/6 activity (PD-03...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.154

    authors: Dean JL,Thangavel C,McClendon AK,Reed CA,Knudsen ES

    更新日期:2010-07-15 00:00:00

  • Identification of two translational products for c-myb.

    abstract::The c-myb gene is the normal cellular homolog of v-myb, the oncogenic component of Avian Myeloblastosis Virus (AMV). The c-myb gene has previously been shown to code for a single protein species of about 75 kd. However, accumulating evidence indicates that this gene could code for multiple mRNAs as a result of differe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Dudek H,Reddy EP

    更新日期:1989-09-01 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

    abstract::Histone deacetylases (HDACs) catalyse the removal of acetyl groups from the N-terminal tails of histones. All known HDACs can be categorized into one of four classes (I-IV). The class III HDAC or silencing information regulator 2 (Sir2) family exhibits characteristics consistent with a distinctive role in regulation o...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210617

    authors: Vaquero A,Sternglanz R,Reinberg D

    更新日期:2007-08-13 00:00:00

  • The erythropoietin-receptor pathway modulates survival of cancer cells.

    abstract::Anemia in cancer patients is associated with reduced quality of life and local failure after radiation treatment. However, the use of erythropoietin to correct cancer anemia and to improve radiation efficacy was disappointing. Erythropoietin-receptor signaling mainly acts via activation of STAT 5, but also crossactiva...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208140

    authors: Pajonk F,Weil A,Sommer A,Suwinski R,Henke M

    更新日期:2004-11-25 00:00:00

  • Disruption of the BLM gene in ATM-null DT40 cells does not exacerbate either phenotype.

    abstract::Bloom syndrome and ataxia-telangiectasia are autosomal recessive human disorders characterized by immunodeficiency, genome instability and predisposition to develop cancer. Recent data reveal that the products of these two genes, BLM and ATM, interact and function together in recognizing abnormal DNA structures. To in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207276

    authors: Fukao T,Chen P,Ren J,Kaneko H,Zhang GX,Kondo M,Yamamoto K,Furuichi Y,Takeda S,Kondo N,Lavin MF

    更新日期:2004-02-26 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract::Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208325

    authors: May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期:2005-02-03 00:00:00

  • 5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells.

    abstract::Treating lung cancer cell lines using low-dose 5-aza-2'-deoxycytidine (DAC) caused an accumulation of procaspase-9 through mRNA upregulation, but the cells did not undergo apoptosis. However, when cells were treated with DAC and infected with a low dose of a recombinant wild-type p53 adenovirus vector (Ad-p53), a syne...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207381

    authors: Gomyo Y,Sasaki J,Branch C,Roth JA,Mukhopadhyay T

    更新日期:2004-09-02 00:00:00